Jean-Philippe Mateta has been linked with the move away from Crystal Palace in recent months. The 28-year-old has been outstanding for the Eagles, and he has been linked with clubs like Manchester ...

Nuclear submarine manufacturer General Dynamics Electric Boat announced Thursday that it is acquiring the majority of the largely vacant Crystal Mall in Waterford. The acquisition comes a few months ...

There's a ton of paperwork that goes into maintaining your small business — and failure to file something important can result in penalties. One such piece of documentation that businesses should file ...

A U.S. Marine Corps artillery round prematurely detonated over Interstate 5 on Saturday sending metal shrapnel onto a California Highway Patrol (CHP) vehicle during a Marine celebration, according to ...

The bodies of model Lidiane Aline Lorenço and her daughter Miana were discovered at an apartment in Barra da Tijuca, in the southwest of Rio de Janeiro, on Friday, Oct. 10 Lidiane Lorenco/Instagram (2 ...

In recent weeks Prince Andrew has been named in documents released by Jeffrey Epstein’s estate, and his ex-wife Sarah Ferguson has been dropped by charities over an email she is said to have sent to ...

(WGHP) — A musician who has spent years behind bars for child pornography and sex crimes has been killed, the BBC is reporting. Ian Watkins, the former lead singer of the Welsh rock band Lostprophets, ...

Perhaps Bill Belichick’s Navy background will serve him well while he tries to plug some leaks within his embattled North Carolina football program. As stories have emerged describing dysfunction ...

NEWPORT BEACH, Calif. (KABC) -- Reports of an active shooter at a hospital in Newport Beach turned out to be a case of swatting, authorities confirmed Tuesday. Officers responded to Hoag Hospital and ...

In what could be the last piece of federal jobs data released this week if the government shuts down, a new report Tuesday showed that the number of available roles remains low for the year, a sign ...

A phase 3 trial of Priovant Therapeutics’ inflammatory disease prospect brepocitinib has hit its primary endpoint, setting the Roivant-backed biotech up to seek FDA approval for the TYK2/JAK1 ...